Live Breaking News & Updates on Angermayer aperion

Stay informed with the latest breaking news from Angermayer aperion on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Angermayer aperion and stay connected to the pulse of your community

Exclusive: German investor Angermayer to launch biotech SPAC in the U.S. – sources

By Arno Schuetze and Nadine Schimroszik
BERLIN (Reuters) - German investor Christian Angermayer is planning to list a blank-cheque company in New York, embracing a trend that has seen a swathe of entrepreneurs tapping into investor interest in new offerings pa, two people close to the matter said.
His Frontier Acquisition Corp., a special purpose acquisition company (SPAC), is planning to sell shares worth $200 million and will have a biotech focus, the sources said, adding that an official filing could take place in the coming days with a listing as early as March.
The SPAC is being sponsored by Angermayer's family office Apeiron Investment Group as well as by venture capital firm Falcon Edge, known for investments in companies like Uber, Delivery Hero, Alibaba and Swipe, they added.

Germany , New-york , United-states , Egypt , France , Berlin , Amsterdam , Noord-holland , Netherlands , French , German , Egyptian

Exclusive: German investor Angermayer to launch biotech SPAC in the U.S. - sources

3 Min Read
BERLIN (Reuters) - German investor Christian Angermayer is planning to list a blank-cheque company in New York, embracing a trend that has seen a swathe of entrepreneurs tapping into investor interest in new offerings, two people close to the matter said.
His Frontier Acquisition Corp., a special purpose acquisition company (SPAC), is planning to sell shares worth $200 million and will have a biotech focus, the sources said, adding that an official filing could take place in the coming days with a listing as early as March.
The SPAC is being sponsored by Angermayer’s family fund Apeiron Investment Group as well as by venture capital firm Falcon Edge, known for investments in companies like Uber, Delivery Hero, Alibaba and Swipe, they added.

Germany , New-york , United-states , Egypt , France , Berlin , Amsterdam , Noord-holland , Netherlands , French , German , Egyptian

Exclusive: German investor Angermayer to launch biotech SPAC in the U.S. - sources

Exclusive: German investor Angermayer to launch biotech SPAC in the U.S. - sources
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

Germany , New-york , United-states , Egypt , France , Berlin , Amsterdam , Noord-holland , Netherlands , French , German , Egyptian